| |
| |
|
| Insider
Information: |
Shandell Jason B. |
| Relationship: |
President and General ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
179,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,171,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,276 |
|
|
| Total
Value |
$7,171,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
President and General ... |
2020-03-17 |
179,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
75,022 |
238,240 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
64,466 |
188,575 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
63,670 |
266,871 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-09-26 |
4 |
AS |
$19.50 |
$1,111,268 |
D/D |
(56,996) |
202,961 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-09-26 |
4 |
OE |
$10.93 |
$622,966 |
D/D |
56,996 |
259,957 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2015-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,167 |
170,076 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,919 |
256,867 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,050 |
199,540 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-08 |
4 |
OE |
$10.46 |
$385,711 |
D/D |
36,201 |
235,706 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-08 |
4 |
AS |
$20.68 |
$748,586 |
D/D |
(36,201) |
199,505 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-01-08 |
4 |
AS |
$18.44 |
$460,978 |
D/D |
(25,000) |
138,898 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-01-08 |
4 |
OE |
$10.93 |
$273,250 |
D/D |
25,000 |
163,898 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-03-15 |
4 |
AS |
$20.34 |
$498,441 |
D/D |
(24,508) |
160,490 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-03-15 |
4 |
OE |
$10.93 |
$267,872 |
D/D |
24,508 |
184,998 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-28 |
4 |
AS |
$20.47 |
$497,201 |
D/D |
(24,292) |
202,961 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-28 |
4 |
OE |
$10.93 |
$265,512 |
D/D |
24,292 |
227,253 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-06 |
4 |
OE |
$14.40 |
$315,835 |
D/D |
21,933 |
160,831 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-06 |
4 |
AS |
$19.83 |
$434,951 |
D/D |
(21,933) |
138,898 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-12-03 |
4 |
OE |
$10.48 |
$174,282 |
D/D |
16,630 |
200,445 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-12-03 |
4 |
AS |
$22.44 |
$373,177 |
D/D |
(16,630) |
183,815 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-09 |
4 |
OE |
$10.46 |
$168,354 |
D/D |
16,095 |
215,600 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-09 |
4 |
AS |
$20.99 |
$337,834 |
D/D |
(16,095) |
199,505 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-05 |
4 |
OE |
$14.40 |
$224,856 |
D/D |
15,615 |
154,513 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-05 |
4 |
AS |
$19.57 |
$305,554 |
D/D |
(15,615) |
138,898 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-01-23 |
4 |
AS |
$22.39 |
$347,019 |
D/D |
(15,497) |
168,318 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
